5TNF-α and IL-1β neutralization ameliorates angiotensin II-induced cardiac damage in male mice

Endocrinology

Volumn 155, Issue 7, 2014, Pages 2677-2687

  Wang, Yueli ^a   Li, Yulin ^a   Wu, Yina ^a   Jia, Lixin ^a   Wang, Jijing ^a   Xie, Bo ^b   Hui, Mizhou ^b   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF PROCESS ENGINEERING   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN TYPE 1; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CELL DIFFERENTIATION; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; FIBROBLAST; HEART INJURY; HEART MUSCLE FIBROSIS; HUMAN; HUMAN CELL; HYPERTENSION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

ANGIOTENSIN II; ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; HEART DISEASES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKIN-6; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCARDIUM; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903288849     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-2065     Document Type: Article

References (48)

1. Shimosawa T. Hypertension and its related organ damage-pathophysiology and new diagnostic strategy. Rinsho Byori. 2013;61:263-270.
2. Marvar PJ, Thabet SR, Guzik TJ, et al. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res. 2010;107:263-270.
3. Yanes LL, Romero DG, Iliescu R, Zhang H, Davis D, Reckelhoff JF. Postmenopausal hypertension: role of the renin-angiotensin system. Hypertension. 2010;56:359-363.
4. Venegas-Pont M, Manigrasso MB, Grifoni SC, et al. Tumor necrosis factor-α antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension. 2010;56:643-649.
5. Zhang JD, Patel MB, Song YS, et al. A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circ Res. 2012;110:1604-1617.
6. Han YL, Li YL, Jia LX, et al. Reciprocal interaction between macrophages and T cells stimulates IFN-γ and MCP-1 production in Ang II-induced cardiac inflammation and fibrosis. PLoS One. 2012;7:e35506.
7. Jia LX, Qi GM, Liu O, et al. Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. Cardiovasc Drugs Ther. 2013;27:521-530.
8. Brands MW, Banes-Berceli AK, Inscho EW, Al-Azawi H, Allen AJ, Labazi H. Interleukin 6 knockout prevents angiotensin II hypertension: role of renal vasoconstriction and janus kinase 2/signal transducer and activator of transcription 3 activation. Hypertension. 2010;56:879-884.
9. Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6:232-241.
10. Kleinbongard P, Schulz R, Heusch G. TNFα in myocardial ischemia/reperfusion, remodeling and heart failure. Heart Fail Rev. 2011;16:49-69.
11. Zhang L, Berta T, Xu ZZ, Liu T, Park JY, Ji RR. TNF-α contributes to spinal cord synaptic plasticity and inflammatory pain: distinct role of TNF receptor subtypes 1 and 2. Pain. 2011;152:419-427.
12. Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140:821-832.
13. Abbate A, Van Tassell BW, Biondi-Zoccai GG. Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. BioDrugs. 2012;26:217-233.
14. Abbate A, Salloum FN, Vecile E, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008;117:2670-2683.
15. Sun M, Chen M, Dawood F, et al. Tumor necrosis factor-α mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation. 2007;115:1398-1407. (Pubitemid 46648375)
16. Xie B, Liu S, Wu S, et al. A novel bifunctional protein TNFR2-Fc-IL-1ra (TFI): expression, purification and its neutralization activity of inflammatory factors. Mol Biotechnol. 2013;54:141-147.
17. Liu Z, Wyffels L, Barber C, et al. Characterization of 99mTc-labeled cytokine ligands for inflammation imaging via TNF and IL-1 pathways. Nucl Med Biol. 2012;39:905-915.
18. Leibowitz D, Planer D, Ben-Ivgi F, Weiss AT, Bursztyn M. Tumor necrosis factor and interleukin-6 levels in hypertensive patients with and without left ventricular hypertrophy. Blood Press. 2005;14:21-24. (Pubitemid 40443749)
19. Kuusisto J, Kärjä V, Sipola P, et al. Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart. 2012;98:1007-10013.
20. Kubota T, McTiernan CF, Frye CS, et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-α. Circ Res. 1997;81:627-635. (Pubitemid 27432751)
21. Hori M, Yamaguchi O. Is tumor necrosis factor-α friend or foe for chronic heart failure? Circ Res. 2013;113:492-494.
22. Heberto Herrera Garza E, Herrera Garza JL, et al. Importance of tumor necrosis factor-α in the pathogenesis of heart failure. Rev Esp Cardiol. 2002;55:61-66. (Pubitemid 34144729)
23. von Haehling S, Schefold JC, Lainscak M, Doehner W, Anker SD. Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders. Heart Fail Clin. 2009;5:549-560.
24. Liu Z, Barber C, Wan L, et al. SPECT imaging of inflammatory response in ischemic-reperfused rat hearts using a 99mTc-labeled dual-domain cytokine ligand. J Nucl Med. 2013;54:2139-2145.
25. Shahid M, Francis J, Majid DS. Tumor necrosis factor-α induces renal vasoconstriction as well as natriuresis in mice. Am J Physiol Renal Physiol. 2008;295:1836-1844.
26. Li Y, Zhang C, Wu Y, et al. Interleukin-12p35 deletion promotes CD4T-cell-dependent macrophage differentiation and enhances angiotensin II-Induced cardiac fibrosis. Arterioscler Thromb Vasc Biol. 2012;32:1662-1674.
27. Harrison DG, Guzik TJ, Lob HE, et al. Inflammation, immunity, and hypertension. Hypertension. 2011;57:132-140.
28. Jia L, Li Y, Xiao C, Du J. Angiotensin II induces inflammation leading to cardiac remodeling. Front Biosci (Landmark Ed). 2012;17:221-231.
29. Bujak M, Frangogiannis NG. The role of IL-1 in the pathogenesis of heart disease. Arch Immunol Ther Exp (Warsz). 2009;57:165-176.
30. Dong S, Hughes RC. Macrophage surface glycoproteins binding to galectin-3 (Mac-2-antigen). Glycoconj J. 1997;14:267-274. (Pubitemid 27144178)
31. Vigetti D, Genasetti A, Karousou E, et al. Proinflammatory cytokines induce hyaluronan synthesis and monocyte adhesion inhuman endothelial cells through hyaluronan synthase 2 (HAS2) and the nuclear factor-κB (NF-κB) pathway. J Biol Chem. 2010;285:24639-24645.
32. Wang L, Reinach P, Lu L. TNF-α promotes cell survival through stimulation of K+ channel and NFκB activity in corneal epithelial cells. Exp Cell Res. 2005;311:39-48. (Pubitemid 41527173)
33. Bayat H, Schröder K, Pimentel DR, et al. Activation of thromboxane receptor modulates interleukin-1β-induced monocyte adhesion-a novel role of Nox1. Free Radic Biol Med. 2012;52:1760-1766.
34. Lu Y, Zhu X, Liang GX, et al. Apelin-APJ induces ICAM-1, VCAM-1 and MCP-1 expression via NF-κB/JNK signal pathway in human umbilical vein endothelial cells. Amino Acids. 2012;43:2125-2136.
35. Elmarakby AA, Quigley JE, Imig JD, Pollock JS, Pollock DM. TNF-α inhibition reduces renal injury in DOCA-salt hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2008;294:76-83.
36. Markó L, Kvakan H, Park JK, et al. Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage. Hypertension. 2012;60:1430-1436.
37. Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. J Hum Hypertens. 2005;19:149-154. (Pubitemid 40220638)
38. Marvar PJ, Lob H, Vinh A, Zarreen F, Harrison DG. The central nervous system and inflammation in hypertension. Curr Opin Pharmacol. 2011;11:156-161.
39. Carnevale D, Lembo G. PI3Kγ in hypertension: a novel therapeutic target controlling vascular myogenic tone and target organ damage. Cardiovasc Res. 2012;95:403-408.
40. Xu S, Zhi H, Hou X, Cohen RA, Jiang B. IκBβ attenuates angiotensin II-induced cardiovascular inflammation and fibrosis in mice. Hypertension. 2011;58:310-316.
41. Qamar A, Rader DJ. Effect of interleukin 1β inhibition in cardiovascular disease. Curr Opin Lipidol. 2012;23:548-553.
42. Vandevyver S, Dejager L, Van Bogaert T, et al. Glucocorticoid receptor dimerization induces MKP1 to protect against TNF-induced inflammation. J Clin Invest. 2012;122:2130-2140.
43. Yang YN, Wang F, Zhou W, Wu ZQ, Xing YQ. TNF-α stimulates MMP-2 and MMP-9 activities in human corneal epithelial cells via the activation of FAK/ERK signaling. Ophthalmic Res. 2012;48:165-170.
44. Nishikawa K, Yoshida M, Kusuhara M, et al. Left ventricular hypertrophy in mice with a cardiac-specific overexpression of interleukin-1. Am J Physiol Heart Circ Physiol. 2006;291:176-183.
45. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-α in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension. 2008;51:1345-1351. (Pubitemid 351555948)
46. Sheedy FJ, Moore KJ. IL-1 signaling in atherosclerosis: sibling rivalry. Nat Immunol. 2013;14:1030-1032.
47. Savoia C, Burger D, Nishigaki N, Montezano A, Touyz RM. Angiotensin II and the vascular phenotype in hypertension. Expert Rev Mol Med. 2011;13:e11.
48. Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev. 2012;13:136-149.